AtaiBeckley (ATAI) Share-based Compensation (2020 - 2026)

AtaiBeckley (ATAI) recorded quarterly Share-based Compensation of $5.4 million in Q1 2026, up 62.38% quarter-over-quarter from $3.4 million in Q1 2025, and up 62.38% on a YoY basis from $3.4 million in Q1 2025.

AtaiBeckley (ATAI) Share-based Compensation (2020 - 2026) Analysis & Trends

AtaiBeckley has disclosed Share-based Compensation across 6 years of filings, most recently posting $9000.0 for Q2 2025.

  • Share-based Compensation for Q2 2025 came in at $9000.0, down 99.61% year-over-year; the trailing twelve-month figure through Sep 2025 was $11.8 million (down 23.62% YoY), and the FY2024 annual result was $25.5 million, down 22.72% from the prior year.
  • Share-based Compensation was $5.4 million for Q1 2026 at AtaiBeckley, up from $3.4 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $5.4 million in Q1 2026 to a low of $3.4 million in Q1 2025.
  • The 5-year median for Share-based Compensation is $6.9 million (2023), against an average of $6.5 million.
  • Across the five-year window, Share-based Compensation jumped 4715.09% in 2022 and slumped 99.78% in 2024, its largest moves.
  • AtaiBeckley's Share-based Compensation stood at $13.4 million in 2021, then slipped by 9.39% to $12.1 million in 2022, then plunged by 39.83% to $7.3 million in 2023, then grew by 15.02% to $8.4 million in 2024, then slumped by 99.89% to $9000.0 in 2025.
  • The last three Share-based Compensation figures came in at $9000.0 (Q2 2025), $3.4 million (Q1 2025), and $8.4 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 305,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 166.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - 26.47 Mn
10 AtaiBeckley 1.45 Bn 1.45 Bn - 5.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.45 Mn
Mar 31, 2026 5.45 Mn
Jun 30, 2025 9,000.00
Jun 30, 2025 9,000.00
Mar 31, 2025 3.36 Mn
Mar 31, 2025 3.36 Mn
Mar 31, 2025 3.36 Mn
Mar 31, 2025 3.36 Mn
Dec 31, 2024 8.40 Mn
Dec 31, 2024 8.40 Mn
Sep 30, 2024 15,000.00
Sep 30, 2024 15,000.00
Jun 30, 2024 2.33 Mn
Jun 30, 2024 2.33 Mn
Mar 31, 2024 5.76 Mn
Mar 31, 2024 5.76 Mn
Dec 31, 2023 7.31 Mn
Dec 31, 2023 7.31 Mn
Sep 30, 2023 6.90 Mn
Sep 30, 2023 6.90 Mn